HU Ming-tao, LI Yu-hong, LI Ying. Triple Regimen Is Preferred in Adjuvant Chemotherapy for Pancreatic Cancer[J]. Journal of Evidence-Based Medicine, 2019, 19(5): 273-276. DOI: 10.12019/j.issn.1671-5144.2019.05.006
|
Citation:
|
HU Ming-tao, LI Yu-hong, LI Ying. Triple Regimen Is Preferred in Adjuvant Chemotherapy for Pancreatic Cancer[J]. Journal of Evidence-Based Medicine, 2019, 19(5): 273-276. DOI: 10.12019/j.issn.1671-5144.2019.05.006
|
HU Ming-tao, LI Yu-hong, LI Ying. Triple Regimen Is Preferred in Adjuvant Chemotherapy for Pancreatic Cancer[J]. Journal of Evidence-Based Medicine, 2019, 19(5): 273-276. DOI: 10.12019/j.issn.1671-5144.2019.05.006
|
Citation:
|
HU Ming-tao, LI Yu-hong, LI Ying. Triple Regimen Is Preferred in Adjuvant Chemotherapy for Pancreatic Cancer[J]. Journal of Evidence-Based Medicine, 2019, 19(5): 273-276. DOI: 10.12019/j.issn.1671-5144.2019.05.006
|
DownLoad: